PharmaEssentia sets up a new R&D facility in the Boston Area
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
The centre will initially employ 170 engineers, bringing the total number of Boston Scientific’s R&D employees in India to more than 300
The transaction is anticipated to close in the first quarter of 2022
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Sumitomo Chemical began its nucleic acid drug substance contract manufacturing business in 2013
This collaboration positions WACKER and RNAV8 as premium mRNA service providers
Abbott's investigational Coronary Intravascular Lithotripsy (IVL) System offers a new potential treatment by using sound pressure waves to treat arterial calcium blockages
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
This acquisition positions Suven as a key player in one of the fastest growing segments of the Pharma CDMO landscape
New research labs and process development services to enable next generation therapeutics
Subscribe To Our Newsletter & Stay Updated